Schroder Investment Management Group Royalty Pharma PLC Transaction History

Schroder Investment Management Group

  • $101 Billion
  • Q4 2024

A detailed history of Schroder Investment Management Group transactions in Royalty Pharma PLC stock. As of the latest transaction made, Schroder Investment Management Group holds 196,359 shares of RPRX stock, worth $6.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
196,359
Previous 550,842 64.35%
Holding current value
$6.56 Million
Previous $15.6 Million 67.86%
% of portfolio
0.0%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
SELL
$24.28 - $28.39 $8.61 Million - $10.1 Million
-354,483 Reduced 64.35%
196,359 $5.01 Million
Q3 2024

Nov 13, 2024
BUY
$25.63 - $29.27 $66,176 - $75,575
2,582 Added 0.47%
550,842 $15.6 Million
Q2 2024

Aug 12, 2024
SELL
$26.26 - $29.9 $129,671 - $147,646
-4,938 Reduced 0.89%
548,260 $14.5 Million
Q1 2024

May 14, 2024
BUY
$27.46 - $31.33 $12.4 Million - $14.2 Million
451,942 Added 446.34%
553,198 $16.8 Million
Q4 2023

Feb 13, 2024
BUY
$26.21 - $29.22 $2.32 Million - $2.59 Million
88,678 Added 705.02%
101,256 $2.84 Million
Q3 2023

Nov 14, 2023
SELL
$26.26 - $31.38 $5.76 Million - $6.88 Million
-219,241 Reduced 94.57%
12,578 $341,000
Q2 2023

Aug 11, 2023
BUY
$29.6 - $36.56 $86,550 - $106,901
2,924 Added 1.28%
231,819 $7.13 Million
Q1 2023

May 11, 2023
SELL
$32.77 - $39.4 $10,453 - $12,568
-319 Reduced 0.14%
228,895 $8.25 Million
Q4 2022

Feb 10, 2023
BUY
$39.17 - $44.04 $570,041 - $640,914
14,553 Added 6.78%
229,214 $9.06 Million
Q3 2022

Nov 10, 2022
SELL
$39.88 - $44.65 $649,764 - $727,482
-16,293 Reduced 7.05%
214,661 $8.63 Million
Q2 2022

Aug 11, 2022
BUY
$37.53 - $44.22 $1.36 Million - $1.6 Million
36,105 Added 18.53%
230,954 $9.72 Million
Q1 2022

May 16, 2022
BUY
$37.46 - $42.44 $1.03 Million - $1.17 Million
27,517 Added 16.44%
194,849 $7.6 Million
Q4 2021

Feb 14, 2022
BUY
$35.17 - $42.48 $837,116 - $1.01 Million
23,802 Added 16.58%
167,332 $6.67 Million
Q3 2021

Nov 12, 2021
SELL
$36.14 - $42.24 $50,523 - $59,051
-1,398 Reduced 0.96%
143,530 $5.19 Million
Q2 2021

Aug 13, 2021
BUY
$39.85 - $46.63 $115,325 - $134,947
2,894 Added 2.04%
144,928 $5.94 Million
Q1 2021

May 17, 2021
BUY
$42.34 - $52.82 $836,299 - $1.04 Million
19,752 Added 16.15%
142,034 $6.2 Million
Q4 2020

Feb 16, 2021
SELL
$36.12 - $50.05 $68,158 - $94,444
-1,887 Reduced 1.52%
122,282 $6.12 Million
Q3 2020

Nov 13, 2020
BUY
$38.56 - $48.36 $1.02 Million - $1.28 Million
26,563 Added 27.21%
124,169 $5.27 Million
Q2 2020

Aug 13, 2020
BUY
$44.5 - $52.11 $4.34 Million - $5.09 Million
97,606 New
97,606 $4.74 Million

Others Institutions Holding RPRX

# of Institutions
429
Shares Held
294M
Call Options Held
508K
Put Options Held
118K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $14.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email